早期系统性红斑狼疮可能沿快速共病/多病轨迹发展,并与疾病复发负担及糖皮质激素暴露相关
该研究为起始队列(诊断≤2年)纳入311例系统性红斑狼疮(SLE)患者,随访5年监测140种共病、疾病活动度、治疗、器官损伤及不良事件/住院。结果显示早期SLE可分为慢速(55%)与快速(45%)共病累积轨迹;快速累积者中又出现3种表型,且与较少达到低疾病活动度/缓解、更多损伤及安全相关事件相关。结论提示近半数新诊断SLE患者共病与多病负担加速累积,需临床警惕。
要点
- 早期SLE可分为慢速与快速共病累积轨迹,快速累积者占45%。
- 快速累积者包含低至中等(一般/非模式化)、代谢-精神、心肺-肌肉骨骼3种表型。
- 前24个月严重复发与糖皮质激素暴露独立预测后续快速共病轨迹。
核心结论
- 早期SLE近半数患者呈现加速的共病与多病负担累积,快速累积表型与复发及糖皮质激素暴露相关,二者为早期疾病中可能可干预的特征。
研究设计与样本
- 起始队列(诊断≤2年)纳入311例SLE患者,随访5年监测140种共病、疾病活动度、治疗、器官损伤及不良事件/住院。
- 采用增长混合模型识别新发共病轨迹,采用四分相关探索性因子分析后聚类定义多病谱,并将轨迹与谱系关联纵向结局。
- 为判断时间顺序,对24-60个月重新拟合轨迹模型,并用惩罚多变量回归评估<24个月的预测因素。
主要发现
- 早期SLE分为慢速(55%)与快速(45%)新发共病轨迹;快速累积者中低至中等(一般/非模式化)占51%、代谢-精神占31%、心肺-肌肉骨骼占18%。
- 三表型多病(≥2种疾病)比例分别为32.7%、65.7%和100%。
- 与慢速累积者相比,快速累积者(尤其代谢-精神与心肺-肌肉骨骼表型)较少达到LLDAS/DORIS,损伤(IRR 2.28-3.27)及安全相关事件(IRR 1.89-3.36)更多。
- 前24个月严重复发(≥20%时间;OR 2.10,95%CI 1.09-4.04)与糖皮质激素暴露(每10 mg/天 OR 1.06,95%CI 1.01-1.11)独立预测后续快速共病轨迹。
- 复发在快速/低至中等及代谢-精神表型中更突出,糖皮质激素使用在心肺-肌肉骨骼表型中更突出。
关键数值与推荐
- 严重复发定义:≥20%时间处于严重复发状态。
- 糖皮质激素暴露以每10 mg/天为单位的OR 1.06(95%CI 1.01-1.11)。
- 多病定义为≥2种疾病;快速累积三表型多病比例分别为32.7%、65.7%、100%。
临床怎么用
- 对新诊断SLE患者应早期识别快速共病累积风险,关注复发负担与糖皮质激素暴露这两项可能可干预因素。
- 可按低至中等、代谢-精神、心肺-肌肉骨骼表型分层监测共病与安全相关事件。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with systemic lupus erythematosus (SLE) carry a substantial comorbidity load associated with worse prognosis, yet most evidence pertains to long-standing disease. How comorbidities-particularly multimorbidity as a marker of overall health burden-evolve at early stages, and whether conditions co-aggregate into clinically meaningful clusters, remains unclear. METHODS: An inception cohort (≤2 years from diagnosis) of 311 patients with SLE with 5-year monitoring of 140 comorbidities, disease activity, treatments, organ damage and adverse events/hospitalisations. Growth mixture modelling identified trajectories of incident comorbidities, while tetrachoric exploratory factor analysis followed by clustering defined multimorbidity profiles; these trajectories and profiles were then related to longitudinal outcomes. To inform temporal ordering, trajectory modelling was refitted for months 24-60, and predictors from <24 months were evaluated using penalised multivariable regression. RESULTS: Early SLE separated into slow (55%) and fast (45%) incident-comorbidity trajectories. Among fast accruers, three phenotypes emerged: low-to-moderate (general/non-patterned) (51%), metabolic-psychiatric (31%) and cardiopulmonary-musculoskeletal (18%), with a gradual increase in multimorbidity (≥2 conditions) (32.7%, 65.7% and 100%, respectively). Compared with slow-accruing, fast-accruing patients-especially the metabolic-psychiatric and cardiopulmonary-musculoskeletal-attained less lupus low disease activity state/Definition of Remission In SLE and developed more damage (incidence rate ratio (IRR) 2.28-3.27) and safety-related events (IRR 1.89-3.36). Severe flares (≥20% of time; OR 2.10, 95% CI 1.09 to 4.04) and glucocorticoid exposure (OR 1.06 per 10 mg/day, 95% CI 1.01 to 1.11) during the first 24 months independently predicted subsequent fast-comorbidity trajectory. Flares were more prominent in the fast/low-to-moderate and metabolic-psychiatric phenotypes, whereas glucocorticoid use was more prominent in the cardiopulmonary-musculoskeletal phenotype. CONCLUSIONS: Nearly half of patients with newly diagnosed SLE show accelerated comorbidity and multimorbidity burden, underscoring the need for clinical vigilance. Fast-accrual phenotypes are linked to flares and glucocorticoid exposure, two potentially modifiable features of early disease.
引用
- Nikoloudaki M, Pitsigavdaki S, Katechis S, et al. Early SLE may follow a fast comorbidity/multimorbidity trajectory associated with flare burden and glucocorticoid exposure. RMD Open. 2026. PMID: 42778333. doi:10.1136/rmdopen-2026-007076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。